Nuvectra to Report Second Quarter 2017 Financial Results on August 8, 2017
July 25 2017 - 04:01PM
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical
device company, announced today that it will release its financial
results for the second quarter ended June 30, 2017 on Tuesday,
August 8, 2017 after market close.
Nuvectra will hold a conference call on Tuesday,
August 8, 2017 at 4:30pm ET to discuss the results. The dial in
numbers are (844) 882-7830 for domestic callers and (574) 990-9704
for international callers. The conference ID is 58530044. A
live webcast of the conference call will be available on the
investor relations section of the Company’s website at
http://investors.nuvectramed.com/.
A replay of the call will be available starting
on August 8, 2017 through August 15, 2017. To access the replay,
dial (855) 859-2056 for domestic callers and (404) 537-3406 for
international callers and enter access code 58530044. The webcast
will be available in the investor relations section of the
Company’s website for 90 days following the completion of the
call.
About Nuvectra Corporation
NuvectraTM is a neurostimulation company committed to helping
physicians improve the lives of people with chronic neurological
conditions. The Algovita® Spinal Cord Stimulation (SCS) System is
our first commercial offering and is CE marked and FDA approved for
the treatment of chronic intractable pain of the trunk and/or
limbs. Our innovative technology platform also has capabilities
under development to support other indications such as sacral
neuromodulation (SNM) for the treatment of overactive bladder, and
deep brain stimulation (DBS) for the treatment of Parkinson’s
Disease. In addition, our NeuroNexus subsidiary designs,
manufactures and markets leading-edge neural-interface technologies
for the neuroscience clinical research market. Visit the Nuvectra
website at www.nuvectramed.com.
Company Contacts:
Nuvectra Corporation
Walter Berger, COO & CFO
(214) 474-3102
wberger@nuvectramed.com
Jennifer Armstrong, Media Relations
(214) 474-3110
jarmstrong@nuvectramed.com
Investor Contacts:
The Ruth Group
Zack Kubow
(646) 536-7020
zkubow@theruthgroup.com
Brian Johnston
(646) 536-7028
bjohnston@theruthgroup.com
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From Feb 2024 to Mar 2024
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From Mar 2023 to Mar 2024